Stay updated on Miransertib in Overgrowth Spectrum Clinical Trial
Sign up to get notified when there's something new on the Miransertib in Overgrowth Spectrum Clinical Trial page.

Latest updates to the Miransertib in Overgrowth Spectrum Clinical Trial page
- Check6 days agoChange DetectedThe MOSAIC study page now indicates that recruitment is closed. It also adds user-guidance sections to help readers understand the study record and how to join.SummaryDifference0.5%

- Check14 days agoChange DetectedThe revision label on the page was updated from v3.5.4 to v3.5.5, indicating a minor maintenance update to the page. No study data, eligibility criteria, or results were altered.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedA new software revision, v3.5.4, was added and the previous revision, v3.5.3, was removed. This indicates an update to the site's underlying platform, likely including fixes or minor enhancements.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page’s displayed ClinicalTrials.gov release/version indicator was updated from “v3.5.2” to “v3.5.3.” This reflects a site revision rather than a change to the study details.SummaryDifference0.0%

- Check64 days agoChange DetectedRevision: v3.5.2 was applied, replacing v3.5.0.SummaryDifference0.0%

- Check92 days agoChange DetectedRevision number updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Miransertib in Overgrowth Spectrum Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Miransertib in Overgrowth Spectrum Clinical Trial page.